Skip to main content

Table 1 Comparison of clinical parameters and biochemical indicators between CRC group and control group [(\( \overline{x} \) ± s, n (%)]

From: High expression of FABP4 and FABP6 in patients with colorectal cancer

Variable

CRC group

(n = 100)

Pa value

Control group (n = 100)

Pb value

Before surgery

After surgery

Age (years)

55.50 ± 8.87

55.50 ± 8.87

NS

53.31 ± 10.58

NS

Sex

 Male

64 (64)

64 (64)

NS

36 (36)

NS

 Female

53 (53)

53 (53)

 

47 (47)

 

Smokers

 Current

21 (21)

21 (21)

NS

30 (30)

NS

 Ex

10 (10)

10 (10)

NS

7 (7)

NS

Alcohol

40 (40)

40 (40)

NS

33 (33)

NS

NSAIDs

16 (16)

16 (16)

NS

10 (10)

NS

Diabetes

6

6

NS

5

NS

Family history of CRC

7 (7)

7 (7)

NS

1 (1)

0.030

BMI (kg/m2)

23.49 ± 2.73

23.42 ± 2.66

NS

22.81 ± 2.78

NS

WC (cm)

84.8 ± 8.6

84.6 ± 8.7

NS

83.5 ± 7.5

0.236

WHR

0.89 ± 0.07

0.89 ± 0.09

NS

0.87 ± 0.07

0.043

SBP (mmHg)

127 ± 16

126 ± 17

NS

128 ± 20

0.940

DBP (mmHg)

79 ± 11

80 ± 12

NS

82 ± 13

0.055

TCH (mmol/L)

4.77 ± 0.92

4.79 ± 0.89

NS

4.37 ± 0.90

0.003

TG (mmol/L)

1.59 ± 0.95

1.57 ± 0.87

NS

1.46 ± 0.80

0.287

LDL-C (mmol/L)

2.89 ± 0.97

2.88 ± 0.93

NS

2.53 ± 0.50

0.001

HDL-C (mmol/L)

1.17 ± 0.49

1.16 ± 0.52

NS

1.65 ± 0.14

0.006

FPG (mmol/L)

6.17 ± 4.45

6.34 ± 4.72

NS

5.50 ± 1.16

NS

FABP4 (pg/ml)

302.24 ± 56.58

268.08 ± 33.92

< 0.001

191.97 ± 53.49

< 0.001

FABP6 (pg/ml)

411.86 ± 83.25

354.64 ± 41.79

< 0.001

289.66 ± 48.57

< 0.001

CEA (ng/ml)

8.88 ± 1.26

6.72 ± 1.32

0.029

5.08 ± 0.81

0.001

CA-199 (U/ml)

14.50 ± 3.39

12.40 ± 4.36

0.048

11.02 ± 2.41

0.004

  1. Abbreviations: NSAID non-steroid anti-inflammatory drug, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, WC waist circumference, WHR waist:hip ratio, TCH total cholesterol, TG triglyceride, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, FPG fasting plasma glucose, FABP4 fatty acid-binding proteins 4, FABP6 fatty acid-binding proteins 6, CEA carcinoembryonic, CA19-9 carbohydrate antigen 19-9, NS non-significant Intergroup comparisions, Pa after surgery vs before surgery, Pb control group vs CRC group before surgery)